Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-051741
Filing Date
2017-09-06
Accepted
2017-09-06 18:13:49
Documents
1
Period of Report
2017-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5869
  Complete submission text file 0001209191-17-051741.txt   7220
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Issuer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERSARTIS, INC. 4200 BOHANNON DRIVE, SUITE 250 MENLO PARK CA 94025
Business Address
Gut Robert (Reporting) CIK: 0001716268 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36361 | Film No.: 171072352